![Julio Enriquez Perez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julio Enriquez Perez
Directeur/Membre du Conseil chez Strominnate Therapeutics AB
Profil
Julio Enriquez Perez has a current job as a Director at Strominnate Therapeutics AB.
Postes actifs de Julio Enriquez Perez
Sociétés | Poste | Début |
---|---|---|
Strominnate Therapeutics AB
![]() Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Strominnate Therapeutics AB
![]() Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Commercial Services |